Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
Past, present, and future of CRISPR genome editing technologies
2024 Standout
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Henning Feist being referenced
Quantitative Assessment of Promoter Hypermethylation during Breast Cancer Development
2002
Surgery as primary treatment in patients with liver metastases from carcinoid tumors: A retrospective, unicentric study over 13 years
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Henning Feist | 155 | 93 | 233 | 183 | 30 | 558 | |
| Yoko Hasumi | 84 | 115 | 235 | 131 | 29 | 508 | |
| Yu. S. Tatarinov | 89 | 77 | 174 | 100 | 38 | 608 | |
| Inbar Ben‐Shachar | 99 | 316 | 115 | 79 | 25 | 639 | |
| Dennis W. Ross | 61 | 28 | 179 | 105 | 37 | 562 | |
| K. K. Dhar | 105 | 140 | 182 | 144 | 29 | 588 | |
| Li Xie | 35 | 43 | 150 | 266 | 29 | 612 | |
| Xufeng Wu | 108 | 138 | 218 | 80 | 31 | 540 | |
| Adela Cimic | 54 | 143 | 226 | 97 | 31 | 536 | |
| Rainer Lehner | 53 | 132 | 255 | 161 | 31 | 608 | |
| K Noda | 180 | 96 | 147 | 256 | 45 | 626 |
All Works
Login with ORCID to disown or claim papers
Loading papers...